Targeted delivery of drugs and proteins to the liver via receptor-mediated endocytosis

Journal of Controlled Release

Volumn 46, Issue 1-2, 1997, Pages 129-137

  Hashida, Mitsuru ^a   Hirabayashi, Hideki ^a   Nishikawa, Makiya ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Galactosylated macromolecules; Hepatic targeting; Liver; Pharmacokinetics; Sugar recognition; Vitamin K5

Indexed keywords

AMYLOSE; ASIALOGLYCOPROTEIN RECEPTOR; CARBOXYMETHYLDEXTRAN; CARBOXYMETHYLSTARCH SODIUM; DRUG CARRIER; GALACTOSE; POLYGLUTAMIC ACID; VITAMIN K GROUP; WARFARIN;

ANIMAL EXPERIMENT; ANTICOAGULATION; CONFERENCE PAPER; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG TARGETING; DRUG TISSUE LEVEL; ENDOCYTOSIS; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031039539     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01577-5     Document Type: Conference Paper

References (35)

1. G. Ashwell and J. Harford, Carbohydrate-specific receptors of the liver, Annu. Rev. Biochem. 51 (1982) 531-554.
2. D.K.F. Meijer and P. van der Sluijs, Covalent and noncovalent protein binding of drugs: Implications for hepatic clearance, storage, and cell-specific drug delivery, Pharm. Res. 6 (1989) 105-118.
3. J.C. Perales, T. Ferkol, M. Molas and R.W. Hanson, An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes, Eur. J. Biochem. 226 (1994) 255-266.
4. A.V. Kabanov and V.A. Kabanov, DNA complexes with polycations for the delivery of genetic material into cells, Bioconjugate Chem. 6 (1995) 7-20.
5. H. Sezaki and M. Hashida, Macromolecule-drug conjugates in targeted cancer chemotherapy, CRC Crit. Rev. Ther. Drug Carrier Syst. 1 (1984) 1-38.
6. M. Hashida, A. Kato, Y. Takakura and H. Sezaki, Disposition and pharmacokinetics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the rat, Drug Metab. Dispos. 12 (1984) 482-499.
7. Y. Takakura, A. Takagi, M. Hashida and H. Sezaki, Disposition and tumor localization of mitomycin C-dextran conjugates in mice, Pharm. Res. 4 (1987) 293-300.
8. Y. Takakura, R. Atsumi, M. Hashida and H. Sezaki, Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. II. Disposition and pharmacokinetics following intravenous and intramuscular administration, Int. J. Pharm. 37 (1987) 145-154.
9. H. Sezaki, Y. Takakura and M. Hashida, Soluble macromolecular carriers for the delivery of anticancer drugs, Adv. Drug Deliv. Rev. 3 (1989) 247-266.
10. M. Hashida and Y. Takakura, Pharmacokinetics in design of polymeric drug delivery systems, J. Control. Release 31 (1994) 163-171.
11. Y. Takakura and M. Hashida, Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs, Crit. Rev. Oncol. Hematol. 18 (1995) 207-231.
12. M. Nishikawa, H. Hirabayashi, Y. Takakura and M. Hashida, Design for cell-specific targeting of proteins utilizing sugar-recognition mechanism: Effect of molecular weight of proteins on targeting efficiency, Pharm. Res. 12 (1995) 209-214.
13. M. Nishikawa, A. Kamijo, T. Fujita, Y. Takakura, H. Sezaki and M. Hashida, Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting, Pharm. Res. 10 (1993) 1253-1261.
14. M. Nishikawa, C. Miyazaki, F. Yamashita, Y. Takakura and M. Hashida, Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties, Am. J. Physiol. 268 (1995) G849-G856.
15. R. Wallin and L.F. Martin, Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo, Biochem. J. 241 (1987) 389-396.
16. Y. Takakura, T. Fujita, M. Hashida and H. Sezaki, Disposition characteristics of macromolecules in tumor-bearing mice, Pharm. Res. 7 (1990) 339-346.
17. Y.C. Lee, C.P. Stowell and M.K. Krantz, 2-imino-2-methoxyethyl 1-thioglycosides: New reagents for attaching sugars to proteins, Biochemistry 15 (1976) 3956-3963.
18. H. Hirabayashi, M. Nishikawa, Y. Takakura and M. Hashida, Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery, Pharm. Res. 13 (1996) 880-884.
19. 2, Angew. Chem. 71 (1959) 7-15.
20. D.J. Hnatowich, W.W. Layne and R.L. Childs, The preparation and labeling of DTPA-coupled albumin, Int. J. Appl. Radiat. Isot. 33 (1982) 327-332.
21. M. Nishikawa, Y. Ohtsubo, J. Ohno, T. Fujita, Y Koyama, F. Yamashita, M. Hashida and H. Sezaki, Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice, Int. J. Pharm. 85 (1992) 75-85.
22. 2 to soluble dextrans. II. In vivo distribution and fate of conjugates, Biochem. Pharmacol. 36 (1987) 113-121.
23. J.R. Duncan and M.J. Welch, Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins, J. Nucl. Med. 34 (1993) 1728-1738.
24. Y. Arano, T. Mukai, T. Uezono, K. Wakisaka, H. Motonari, H. Akizawa, Y. Taoka and A. Yokoyama, A biological method to evaluate bifunctional chelating agents to label antibodies with metallic radionuclides, J. Nucl. Med. 35 (1994) 890-898.
25. S.V. Deshpande, R. Subramanian, M.J. McCall, S.J. De-Nardo, G.L. DeNardo and C.F. Meares, Metabolism of indium chelates attached to monoclonal antibody: Minimal transchelation of indium from benzyl-EDTA chelate in vivo, J. Nucl. Med. 31 (1990) 218-224.
26. K. Yamaoka, Y. Tanigawara, T. Nakagawa and T. Uno, A pharmacokinetic analysis program (MULTI) for microcomputer, J. Pharmacobio-Dyn. 4 (1981) 879-885.
27. W.J. Williams, The activity of human placenta microsomes and brain particles in blood coagulation, J. Biol. Chem. 241 (1966) 1840-1846.
28. B.M. Brenner, T.H. Hostetter and H.D. Humes, Glomerular permselectivity: Barrier function based on discrimination of molecular size and charge, Am. J. Physiol. 234 (1978) F455-F460.
29. K. Mihara, T. Hojo, M. Fujikawa, Y. Takakura, H. Sezaki and M. Hashida, Disposition characteristics of protein drugs in the perfused rat kidney, Pharm. Res. 10 (1993) 823-827.
30. K. Mihara, K. Sawai, Y. Takakura and M. Hashida, Manipulation of renal disposition of human recombinant superoxide dismutase by chemical modification, Biol. Pharm. Bull. 17 (1994) 296-301.
31. D.R. Vera, K.A. Krohn, R.C. Stadalnik and P.O. Scheibe, Tc-99m-galactosyl-neoglycoalbumin: In vitro characterization of receptor-mediated binding, J. Nucl. Med. 25 (1984) 779-787.
32. Y.C. Lee, R.R. Townsend, M.R. Hardy, J. Lünngren, J. Arnarp, M. Haraldsson and H. Lünn, Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features, J. Biol. Chem. 258 (1983) 199-202.
33. R.R. Townsend, M.R. Hardy, T.C. Wong and Y.C. Lee, Binding of N-linked bovine fetuin glycopeptides to isolated rabbit hepatocytes: Gal/GalNAc hepatic lectin discrimination between Galβ(1,4)GalNAc and Galβ(1,3)GalNAc in a triantennary structure, Biochemistry 25 (1986) 5716-5725.
34. S. Miller, J. Janin, A.M. Lask and C. Chothia, Interior and surface of monomeric proteins, J. Mol. Biol. 196 (1987) 641-656.
35. Y. Takakura, T. Fujita, H. Furitsu, M. Nishikawa, H. Sezaki and M. Hashida, Pharmacokinetics of succinylated proteins and dextran sulfate in mice: Implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors, Int. J. Pharm. 105 (1994) 19-29.